<DOC>
	<DOCNO>NCT00250458</DOCNO>
	<brief_summary>Study test effectiveness market drug treatment migraine-associated nausea .</brief_summary>
	<brief_title>Study Test Marketed Product Treatment Migraine-associated Nausea</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Rizatriptan</mesh_term>
	<criteria>6month history migraine , moderate severe migraine attack nausea , 16 migraine attack per month Heart disease , high blood pressure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>